Alexandria New Medical Center (EGX: AMES)

EGX: AMES Statistics

Total Valuation

Alexandria New Medical Center has a market cap or net worth of EGP 2.28 billion. The enterprise value is 2.24 billion.

Market Cap	2.28B
Enterprise Value	2.24B

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Alexandria New Medical Center has 124.58 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	124.58M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.87M

Valuation Ratios

The trailing PE ratio is 174.86.

PE Ratio	174.86
Forward PE	n/a
PS Ratio	7.06
PB Ratio	10.72
P/TBV Ratio	10.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 86.41, with an EV/FCF ratio of -309.89.

EV / Earnings	172.27
EV / Sales	6.95
EV / EBITDA	86.41
EV / EBIT	145.84
EV / FCF	-309.89

Financial Position

The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.03.

Current Ratio	1.51
Quick Ratio	1.37
Debt / Equity	0.03
Debt / EBITDA	0.24
Debt / FCF	-0.87
Interest Coverage	8.26

Financial Efficiency

Return on equity (ROE) is 6.33% and return on invested capital (ROIC) is 4.50%.

Return on Equity (ROE)	6.33%
Return on Assets (ROA)	3.09%
Return on Capital (ROIC)	4.50%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.04
Inventory Turnover	23.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +156.87% in the last 52 weeks. The beta is 0.85, so Alexandria New Medical Center's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	+156.87%
50-Day Moving Average	19.57
200-Day Moving Average	13.49
Relative Strength Index (RSI)	37.91
Average Volume (20 Days)	24,488

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Alexandria New Medical Center had revenue of EGP 322.68 million and earned 13.02 million in profits. Earnings per share was 0.10.

Revenue	322.68M
Gross Profit	85.88M
Operating Income	15.38M
Pretax Income	21.19M
Net Income	13.02M
EBITDA	25.96M
EBIT	15.38M
Earnings Per Share (EPS)	0.10

Balance Sheet

The company has 40.09 million in cash and 6.29 million in debt, giving a net cash position of 33.80 million or 0.27 per share.

Cash & Cash Equivalents	40.09M
Total Debt	6.29M
Net Cash	33.80M
Net Cash Per Share	0.27
Equity (Book Value)	212.53M
Book Value Per Share	1.71
Working Capital	54.56M

Cash Flow

In the last 12 months, operating cash flow was 30.67 million and capital expenditures -37.91 million, giving a free cash flow of -7.24 million.

Operating Cash Flow	30.67M
Capital Expenditures	-37.91M
Free Cash Flow	-7.24M
FCF Per Share	-0.06

Margins

Gross margin is 26.62%, with operating and profit margins of 4.77% and 4.04%.

Gross Margin	26.62%
Operating Margin	4.77%
Pretax Margin	6.57%
Profit Margin	4.04%
EBITDA Margin	8.05%
EBIT Margin	4.77%
FCF Margin	n/a

Dividends & Yields

Alexandria New Medical Center does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.57%
FCF Yield	-0.32%

Stock Splits

The last stock split was on May 9, 2024. It was a forward split with a ratio of 8.

Last Split Date	May 9, 2024
Split Type	Forward
Split Ratio	8

Scores

Alexandria New Medical Center has an Altman Z-Score of 7.2.

Altman Z-Score	7.2
Piotroski F-Score	n/a